Eastman Chemical to Acquire Genovique Specialties

Eastman Chemical said on Wednesday it will acquire Genovique Specialties in a deal that will increase its footprint in the growing market for specialty plasticizers. Financial details of the transaction were not disclosed, but Eastman said it expected the deal to boost its full-year 2010 earnings.

The transaction was also announced by Arsenal Capital Partners, a New York-based private equity firm which owns Genovique Specialties.

Eastman said the acquisition will establish the company as a global leader in non-phthalate plasticizers. Plasticizers or dispersants are additives that increase the plasticity or fluidity of a material such as plastics, cement and concrete.

Genovique Specialties, including its manufacturing operations in Chestertown, Md., Estonia, and a joint venture in Wuhan, China, will become part of Eastman's Performance Chemicals and Intermediates segment.

 

Company

Eastman Chemical Company

200 South Wilcox Drive
37662 Kingsport

Company contact







Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.